DarioHealth to Report Fourth Quarter and Full Year 2024 Results on Monday, March 10, 2025

Rhea-AI Summary

DarioHealth Corp (Nasdaq: DRIO), a digital health market leader, has scheduled its Q4 and full-year 2024 financial results announcement for Monday, March 10th, 2025, before market opening. The company will host a conference call and webcast at 8:30 AM ET, featuring CEO Erez Raphael and CCO Steven Nelson.

Participants can join via phone using domestic (1-800-717-1738) or international (1-646-307-1865) dial-in numbers, or through the Call me™ link available 15 minutes before the event. A webcast option is also available. The earnings call replay will be accessible until March 24th, 2025, using replay passcode 1134608.

Company to host conference call and webcast at 8:30am Eastern Time

NEW YORK, March 4, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today that it will release its financial results for the 4^th quarter ended December 31^st, 2024 and will host a conference call and webcast at 8:30 am Eastern Time, on Monday, March 10^th, 2025, before the market opens.

Erez Raphael, Chief Executive Officer, and Steven Nelson, Chief Commercial Officer, will host the call.

Conference Call Details

Date: Monday, March 10^th, 2025, 8:30am ET

Dial-in Number: 1-800-717-1738 (domestic) or 1-646-307-1865 (international)

Call me™: https://emportal.ink/41htore

Participants can use the dial-in numbers above and be answered by an operator OR click the Call me™ link for instant telephone access to the event. This link will be made active 15 minutes prior to scheduled start time.

Webcast link: https://viavid.webcasts.com/starthere.jsp?ei=1708830&tp_key=417ae4f4c3

Participants are asked to dial in approximately 10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion of the conference call through Monday, March 24^th, 2025. To listen to the replay, dial 1-844-512-2921 (domestic) or 1-412-317-6671 (international) and use replay passcode 1134608.

About DarioHealth Corp.

DarioHealth Corp. (Nasdaq: DRIO) is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multi-chronic condition digital therapeutics platform. Dario's platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. 

Dario's user-centric platform offers people continuous and customized care for their health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results and making the right thing to do the easy thing to do.

Dario provides its highly user-rated solutions globally to health plans and other payers, self-insured employers, providers of care and consumers. To learn more about Dario and its digital health solutions, or for more information, visit http://dariohealth.com.

Cautionary Note Regarding Forward-Looking Statements

This news release and the statements of representatives and partners of DarioHealth Corp. related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company is using forward-looking statements in this press release when it discusses the expected date of its earnings release. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results (including, without limitation, the timing for and results of the Company's commercial and regulatory plans for Dario™ as described herein) may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

DarioHealth Corporate Contact
Mary Mooney
VP Marketing
mary@dariohealth.com
+1-312-593-4280

DarioHealth Investor Relations Contact
Kat Parrella
Investor Relations Manager
kat@dariohealth.com
+315-378-6922

View original content:https://www.prnewswire.com/news-releases/dariohealth-to-report-fourth-quarter-and-full-year-2024-results-on-monday-march-10-2025-302391311.html

SOURCE DarioHealth Corp.

FAQ

When will DarioHealth (DRIO) release its Q4 2024 earnings?

DarioHealth will release Q4 2024 earnings on Monday, March 10th, 2025, before market opens.

How can investors join DRIO's Q4 2024 earnings call?

Investors can join via phone (1-800-717-1738 domestic, 1-646-307-1865 international), Call me™ link, or webcast at 8:30 AM ET.

Who will be presenting at DarioHealth's Q4 2024 earnings call?

CEO Erez Raphael and Chief Commercial Officer Steven Nelson will host the call.

How long will DRIO's Q4 2024 earnings call replay be available?

The replay will be available until March 24th, 2025, using passcode 1134608.